The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The first medication for obstructive sleep apnea has been approved ... The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA noted. Sally Seymour, M.D ...

It should be used with a reduced-calorie diet and ... the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug ... with a diet including ≤20 g fat per day. Tryngolza is self-administered once monthly via an autoinjector. The FDA approval ...

The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...

The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...

23, 2024 -- The FDA has approved ... drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when combined with a low ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...